1. Acute tumor lysis syndrome caused by transcatheter oily chemoembolization in a patient with a large hepatocellular carcinoma.
- Author
-
Sakamoto N, Monzawa S, Nagano H, Nishizaki H, Arai Y, and Sugimura K
- Subjects
- Angiography, Carcinoma, Hepatocellular blood supply, Carcinoma, Hepatocellular diagnostic imaging, Dose-Response Relationship, Drug, Fatal Outcome, Gelatin Sponge, Absorbable, Humans, Liver Neoplasms blood supply, Liver Neoplasms diagnostic imaging, Male, Middle Aged, Retreatment, Tomography, Spiral Computed, Tumor Lysis Syndrome diagnostic imaging, Carcinoma, Hepatocellular therapy, Chemoembolization, Therapeutic adverse effects, Contrast Media, Epirubicin adverse effects, Iodized Oil, Liver Neoplasms therapy, Tumor Lysis Syndrome etiology
- Abstract
Acute tumor lysis syndrome results from a sudden and rapid release of products of cellular breakdown after anticancer therapy. Severe alterations of metabolic profile might occur and result in acute renal failure. We present a patient with a large hepatocellular carcinoma who received transcatheter oily chemoembolization and died subsequently of this syndrome. To our knowledge, there has been only one report of this syndrome induced by chemoembolization for hepatocellular carcinoma. This case illustrates the need to anticipate the development of acute tumor lysis syndrome when chemoembolization is planned for a large hepatocellular carcinoma.
- Published
- 2007
- Full Text
- View/download PDF